Business Wire

Seattle Genetics and Astellas Announce Submission of Biologics License Application to FDA for Enfortumab Vedotin for Patients with Locally Advanced or Metastatic Urothelial Cancer

Seattle Genetics, Inc. is an emerging multi-product, global biotechnology company that develops and commercializes transformative therapies targeting cancer to make a meaningful difference in people’s ...
Reuters

Seattle Genetics to buy Bothell plant from Bristol-Myers Squibb

* Seattle Genetics - ‍signed definitive agreements to purchase Bristol-Myers Squibb's pharmaceutical manufacturing facility in Bothell, Washington * Seattle Genetics - ‍intends to offer employment to ...
Business Wire

Seattle Genetics to Present at Morgan Stanley Global Healthcare Conference

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (NASDAQ:SGEN) announced today that management will present at the Morgan Stanley Global Healthcare Conference on Tuesday, September 12, 2017 at ...
komonews

Seattle Genetics announces Pfizer collaboration

BOTHELL, Wash. (AP) - Biotechnology company Seattle Genetics Inc. said Thursday it will receive an $8 million fee from Pfizer Inc. for rights to use its cancer-fighting antibody-drug conjugate ...
WTOP News

Seattle Genetics: Q3 Earnings Snapshot

BOTHELL, Wash. (AP) — BOTHELL, Wash. (AP) — Seattle Genetics Inc. (SGEN) on Wednesday reported a loss of $215.8 million in its third quarter. The Bothell, Washington-based company said it had a loss ...
WTOP News

Seattle Genetics: Q2 Earnings Snapshot

BOTHELL, Wash. (AP) — BOTHELL, Wash. (AP) — Seattle Genetics Inc. (SGEN) on Wednesday reported a loss of $211.5 million in its second quarter. On a per-share basis, the Bothell, Washington-based ...